Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-09-30
1993-10-26
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 45, 514258, 514261, 536 276, 536 2761, 536 2762, 536 2763, 544262, 544277, C07H 1906, C07D47330, A61K 3170
Patent
active
052566501
ABSTRACT:
Adenosine analogues which act selectively at adenosine receptors and which act in general as adenosine antagonists are disclosed. From in vitro studies it is known that specific physiological effects can be distinguished as a result of this selectivity and that adenosine receptor activity in vitro correlates with adenosine receptor activity in vivo.
Pharmaceutical preparations of the subject compounds can be prepared on the basis of the selective binding activity of the compounds disclosed herein which will enhance certain physiological effects while minimizing others, such as decreasing blood pressure without decreasing heart rate.
REFERENCES:
patent: 3211732 (1965-10-01), Schmidt
patent: 3225046 (1965-12-01), Zwahlen
patent: 3502649 (1970-03-01), Thiel
patent: 3590029 (1971-06-01), Koch
patent: 3862189 (1975-01-01), Schwender
patent: 4388308 (1983-06-01), Hamilton
patent: 4514405 (1985-04-01), Irmscher
patent: 4853386 (1989-08-01), Friebe
patent: 4904666 (1990-02-01), Friebe
patent: 5043325 (1991-08-01), Olsson
Lentz Nelsen L.
Peet Norton P.
Chay Celia
Ivy C. Warren
Merrell Dow Pharmaceuticals Inc.
Sayles Michael J.
LandOfFree
Selective adenosine receptor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective adenosine receptor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective adenosine receptor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-959498